Literature DB >> 7949214

Patterns of cyclic AMP binding in normal human breast.

S Battersby1, T J Anderson, W R Miller.   

Abstract

Cyclic AMP binding proteins have been measured in normal breast tissue, in a variety of physiological conditions including resting state (69 cases), pregnancy (15 cases), lactation (4 cases), post-lactational involution (6 cases), and prolonged involution (10 cases). Levels varied greatly within the groups but median values were elevated in pregnancy, lactation, and post-lactational involution as compared with the resting and prolonged involutionary states. The proportion of different types of cyclic AMP binding proteins also differed between groups. Resting breast showed approximately equal amounts of type I and II whereas pregnant and postlactational involuting breast tissue had an increased proportion of type I binding, and the prolonged involutionary state tended to be associated with low type I. Within the subgroup of nulliparous resting breasts, the proportion of type I cyclic AMP binding protein was significantly elevated during the second half of the menstrual cycle compared with the first (p < 0.05). There were also significant positive associations between the level of epithelial proliferation and both total (p < 0.015) and type I (p < 0.002) cyclic AMP binding. This represents the strongest of association thus far reported between signalling systems and proliferation in the normal breast.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949214     DOI: 10.1007/bf00666059

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Photoaffinity labeling of a protein kinase from bovine brain with 8-azidoadenosine 3',5'-monophosphate.

Authors:  A H Pomerantz; S A Rudolph; B E Haley; P Greengard
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

2.  Correlation of proliferative activity in breast tissue using PCNA/cyclin.

Authors:  S Battersby; T J Anderson
Journal:  Hum Pathol       Date:  1990-07       Impact factor: 3.466

3.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

Authors:  J J Going; T J Anderson; S Battersby; C C MacIntyre
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

4.  Adenosine 3':5'-monophosphate and hormone interrelationships in the mammary gland of the rat during pregnancy and lactation.

Authors:  M Sapag-Hagar; A L Greenbaum
Journal:  Eur J Biochem       Date:  1974-09-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

Authors:  Y S Cho-Chung
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

7.  Specific regulation by steroid hormones of protein kinases in the endometrium. 2. Alteration in levels of protein kinases in human endometrium during the menstrual cycle.

Authors:  K Miyazaki; E Miyamoto; M Maeyama; M Uchida
Journal:  Eur J Biochem       Date:  1980-03

8.  Proliferative and secretory activity in the pregnant and lactating human breast.

Authors:  S Battersby; T J Anderson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Oligonucleotides antisense to catalytic subunit of cyclic AMP-dependent protein kinase inhibit mouse mammary epithelial cell DNA synthesis.

Authors:  L G Sheffield
Journal:  Exp Cell Res       Date:  1991-01       Impact factor: 3.905

10.  Cyclic AMP binding proteins in human breast cancer.

Authors:  W R Miller; R O Senbanjo; J Telford; D M Watson
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more
  1 in total

1.  Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.

Authors:  J M Bartlett; M J Hulme; W R Miller
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.